Inhibition of abnormal C/EBPβ/α-Syn signaling pathway through activation of Nrf2 ameliorates Parkinson's disease-like pathology.


Journal

Aging cell
ISSN: 1474-9726
Titre abrégé: Aging Cell
Pays: England
ID NLM: 101130839

Informations de publication

Date de publication:
10 2023
Historique:
revised: 24 07 2023
received: 12 12 2022
accepted: 30 07 2023
medline: 23 10 2023
pubmed: 24 8 2023
entrez: 24 8 2023
Statut: ppublish

Résumé

Parkinson's disease (PD) is characterized by the formation of Lewy bodies (LBs) in the brain. These LBs are primarily composed of α-Synuclein (α-Syn), which has aggregated. A recent report proposes that CCAAT/enhancer-binding proteins β (C/EBPβ) may act as an age-dependent transcription factor for α-Syn, thereby initiating PD pathologies by regulating its transcription. Potential therapeutic approaches to address PD could involve targeting the regulation of α-Syn by C/EBPβ. This study has revealed that Nrf2, also known as nuclear factor (erythroid-derived 2)-like 2 (NFE2L2), suppresses the transcription of C/EBPβ in SH-SY5Y cells when treated with MPP

Identifiants

pubmed: 37614147
doi: 10.1111/acel.13958
pmc: PMC10577548
doi:

Substances chimiques

NF-E2-Related Factor 2 0
CEBPB protein, human 0
Cebpb protein, mouse 0
alpha-Synuclein 0
CCAAT-Enhancer-Binding Proteins 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13958

Informations de copyright

© 2023 The Authors. Aging Cell published by Anatomical Society and John Wiley & Sons Ltd.

Références

Nat Rev Neurosci. 2013 Jan;14(1):38-48
pubmed: 23254192
Physiol Rev. 2018 Jul 1;98(3):1169-1203
pubmed: 29717933
Immunobiology. 1995 Jul;193(2-4):171-85
pubmed: 8530141
Proc Natl Acad Sci U S A. 2017 Sep 26;114(39):E8284-E8293
pubmed: 28900002
Proc Natl Acad Sci U S A. 1997 Sep 16;94(19):10367-72
pubmed: 9294217
Mov Disord. 2013 Dec;28(14):1957-65
pubmed: 24108425
Aging Cell. 2023 Mar;22(3):e13745
pubmed: 36437524
Biochem Pharmacol. 2008 Oct 15;76(8):967-73
pubmed: 18755157
Neurochem Int. 2013 Apr;62(5):803-19
pubmed: 23291248
PLoS Biol. 2005 Sep;3(9):e293
pubmed: 16104829
Neuron. 2003 Sep 11;39(6):889-909
pubmed: 12971891
Neuron. 2011 Oct 6;72(1):57-71
pubmed: 21982369
J Neurosci. 2019 Sep 11;39(37):7291-7305
pubmed: 31358653
Mol Psychiatry. 2021 Feb;26(2):568-585
pubmed: 32086435
EMBO J. 2018 Jun 15;37(12):
pubmed: 29769405
Neurotox Res. 2003;5(6):411-8
pubmed: 14715444
Proc Natl Acad Sci U S A. 1994 Apr 12;91(8):3147-50
pubmed: 8159717
Front Neurosci. 2019 Apr 18;13:381
pubmed: 31057362
Science. 2012 Nov 16;338(6109):949-53
pubmed: 23161999
Mov Disord. 2011 Jan;26(1):6-17
pubmed: 21322014
Neurobiol Aging. 2013 May;34(5):1504-15
pubmed: 23200460
Antioxid Redox Signal. 2011 Jun 15;14(12):2347-60
pubmed: 21254817
Prog Neurobiol. 2015 Sep;132:1-33
pubmed: 26143335
Proc Natl Acad Sci U S A. 2017 Oct 3;114(40):10773-10778
pubmed: 28923922
Aging Cell. 2023 Oct;22(10):e13958
pubmed: 37614147
Neuropharmacology. 1999 Jun;38(6):835-42
pubmed: 10465687
AAPS J. 2010 Mar;12(1):87-97
pubmed: 20013083
Free Radic Biol Med. 2015 Nov;88(Pt B):93-100
pubmed: 26117331
J Pharm Pharmacol. 2020 Oct;72(10):1394-1404
pubmed: 32628779
J Biol Chem. 2000 Jan 7;275(1):390-7
pubmed: 10617630
Nat Commun. 2018 May 3;9(1):1784
pubmed: 29725016
Neurobiol Dis. 2021 Jan;148:105218
pubmed: 33296726
Annu Rev Pharmacol Toxicol. 2013;53:401-26
pubmed: 23294312
Mol Nutr Food Res. 2017 Feb;61(2):
pubmed: 27735126
Nat Protoc. 2014 Sep;9(9):2135-46
pubmed: 25122523
Oxid Med Cell Longev. 2013;2013:529219
pubmed: 23819012
Nucleic Acids Res. 2019 Aug 22;47(14):7321-7332
pubmed: 31214713
Nucleic Acids Res. 2021 May 21;49(9):4864-4876
pubmed: 33928345
J Immunol Res. 2020 Sep 28;2020:5093493
pubmed: 33062722
J Biol Chem. 1998 Nov 6;273(45):29279-82
pubmed: 9792624
Trends Pharmacol Sci. 2013 Jun;34(6):340-6
pubmed: 23664668
Nat Neurosci. 2019 Jul;22(7):1099-1109
pubmed: 31235907
Proc Natl Acad Sci U S A. 2017 Jan 31;114(5):1183-1188
pubmed: 28096359
Neuropharmacology. 2020 Jun 15;170:108022
pubmed: 32119885
J Neuroinflammation. 2011 Nov 10;8:156
pubmed: 22074460
Cytokine. 1995 Nov;7(8):753-8
pubmed: 8664441
Sci Rep. 2016 Jul 29;6:30659
pubmed: 27470577
J Biol Chem. 2001 Feb 9;276(6):3879-84
pubmed: 11078745
Nat Commun. 2015 Aug 10;6:7969
pubmed: 26258894
Brain Res Bull. 2005 Feb 15;65(1):87-95
pubmed: 15680548

Auteurs

Zefang Lin (Z)

Department of Physiology, School of Medicine, Jinan University, Guangzhou, China.

Lixuan Huang (L)

Department of Physiology, School of Medicine, Jinan University, Guangzhou, China.

Qianqian Cao (Q)

Department of Physiology, School of Medicine, Jinan University, Guangzhou, China.

Hanyue Luo (H)

Department of Physiology, School of Medicine, Jinan University, Guangzhou, China.

Wei Yao (W)

Guangzhou Key Laboratory of Formula-pattern Research Center, School of Traditional Chinese Medicine, Jinan University, Guangzhou, China.

Ji-Chun Zhang (JC)

Department of Physiology, School of Medicine, Jinan University, Guangzhou, China.
Institute of Brain Science and Brain-inspired Research, Shandong First Medical University & Shandong Academy of Medical Sciences, Jinan, China.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH